Nanotechnology RSS feeds


ENJOY THE BENEFITS

Simply Register to GAIN ACCESS to lots more info

USER LOGIN


copyright-Nanovip 2008

NANO FACTS

...Nanometres...
nanotechnology companies | nanotechnology info Human hair 80,000 nm wide
nanotechnology companies | nanotechnology info Red blood cell 7,000 nm wide
nanotechnology companies | nanotechnology info Water molecule 0.3 nm wide
nanotechnology companies | nanotechnology info Sheet Paper 100,000 nm wide

LATEST MEMBERS

  • zxc
  • duleantonic
  • shirin2
  • dennere
  • ranamomen
  • pustahorse

WHO'S ONLINE

There are currently 0 users and 24 guests online.

  Valid XHTML 1.0 Transitional

Button for your site

In-Q-Tel Inc.


Host Unlimited Websites For Just 1 Cent!
Recommended by Nanovip as No1 Webhost

Address: P.O Box 12407
Zip: 22219

Visit this link

Phone :
703.248.3000

Fax :
703.248.3001

To optimize value for our client the In-Q-Tel Inc. engages with startups, mezzanine and established companies, as well as universities and research labs at a strategic level. We structure attractive win-win relationships through equity investments, product development funding, innovative intellectual property arrangements and commercial and government business development guidance. In-Q-Tel generally invests between $1M to $3M. We lead investment rounds and co-invest with other firms.

We back great entrepreneurial teams with innovative technologies that have the potential to address high growth commercial markets. Commercial success for our partners is critical to achieving our ultimate goal of reducing the total cost of technology ownership to the Intelligence Community. But we are not looking for government-specific solutions. We focus on identifying commercial analogs to the ICs own enterprise problem's where the needs of the market and the IC meet.

» | Edit this entry
                                                                                                                                                                                                                                                                                          
Back to previous page Go to the top of this page